A Competitive Analysis of the Biomanufacturing Strategic Landscape and Technology Stack
Summary
The report finds that while the United States and its partners currently lead in high-value pharmaceutical biomanufacturing, China is rapidly closing the gap and already dominates bulk industrial bioprocessing capacity.
Key insights
- The United States and its partners maintain a strong position across the biomanufacturing technology stack, but China is rapidly expanding and using state support to narrow the gap.
- There is a strategic divergence in focus: Western producers prioritize high-profit margin sectors like pharmaceuticals, whereas Chinese firms focus on strategic manufacturing capacity and supply chain resilience for bulk industrial applications.
- China is better positioned to capture future biomanufacturing applications beyond healthcare due to sustained investment in industrial infrastructure, technology, and supply chains.
- The United States is heavily dependent on partner nations, specifically Germany, Japan, and South Korea, across virtually every layer of the biomanufacturing technology stack.
- China maintains a near-monopoly over many biomanufactured bulk products and controls up to 70 percent of global industrial-grade bioprocessing capacity.
- China possesses significant short-term strategic leverage through its near-complete control over the supply of biomanufacturing additives, such as vitamins and amino acids, which are used in most processes.
- Western firms hold a major source of long-term strategic leverage through their dominance of pharmaceutical-grade bioreactor manufacturing, which controls the infrastructure needed to expand pharmaceutical capacity.
- The United States and its partners dominate the market for target-specific chromatography resins, creating a high-impact source of short-term leverage due to the difficulty of substitution in the pharmaceutical sector.
- China has prioritized the development of second-generation (lignocellulosic) feedstocks to reduce its reliance on food crops, whereas the United States has seen limited success in this area due to the abundance of cheap first-generation feedstocks.
Cite the original document
- APA
- Fluegel, L. (2026). A Competitive Analysis of the Biomanufacturing Strategic Landscape and Technology Stack. Carnegie Endowment for International Peace. https://assets.carnegieendowment.org/files/Fluegel_Biomanufacturing.pdf
- Chicago
- Fluegel, Lucas. A Competitive Analysis of the Biomanufacturing Strategic Landscape and Technology Stack. Carnegie Endowment for International Peace, 2026. https://assets.carnegieendowment.org/files/Fluegel_Biomanufacturing.pdf.
- Wikipedia
- {{cite report |last1=Fluegel |first1=Lucas |title=A Competitive Analysis of the Biomanufacturing Strategic Landscape and Technology Stack |publisher=Carnegie Endowment for International Peace |date=July 2026 |url=https://assets.carnegieendowment.org/files/Fluegel_Biomanufacturing.pdf |access-date=5 November 2026 |via=Climate Insights Directory (document carnend-003001)}}
- BibTeX
- @techreport{fluegel2026competitive, author = {Fluegel, Lucas}, title = {{A Competitive Analysis of the Biomanufacturing Strategic Landscape and Technology Stack}}, institution = {Carnegie Endowment for International Peace}, year = {2026}, month = jul, url = {https://assets.carnegieendowment.org/files/Fluegel_Biomanufacturing.pdf}, urldate = {2026-11-05}, note = {Indexed by Climate Insights Directory, document carnend-003001} }
Full text
Collected · Record updated